CN107772330A - 一种复方无花果冻干粉含片 - Google Patents
一种复方无花果冻干粉含片 Download PDFInfo
- Publication number
- CN107772330A CN107772330A CN201610747603.7A CN201610747603A CN107772330A CN 107772330 A CN107772330 A CN 107772330A CN 201610747603 A CN201610747603 A CN 201610747603A CN 107772330 A CN107772330 A CN 107772330A
- Authority
- CN
- China
- Prior art keywords
- freeze
- dried powder
- compound
- eucalyptus oil
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000843 powder Substances 0.000 title claims abstract description 30
- 150000001875 compounds Chemical class 0.000 title claims abstract description 22
- 239000007937 lozenge Substances 0.000 title claims abstract description 13
- 229940044949 eucalyptus oil Drugs 0.000 claims abstract description 20
- 239000010642 eucalyptus oil Substances 0.000 claims abstract description 20
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 12
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 3
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- 229940046011 buccal tablet Drugs 0.000 claims description 3
- 239000006189 buccal tablet Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims 4
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims 2
- 244000037364 Cinnamomum aromaticum Species 0.000 claims 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims 2
- 239000005844 Thymol Substances 0.000 claims 2
- 229930008380 camphor Natural products 0.000 claims 2
- 229960000790 thymol Drugs 0.000 claims 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 1
- 241000723346 Cinnamomum camphora Species 0.000 claims 1
- 229920000742 Cotton Polymers 0.000 claims 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims 1
- 244000246386 Mentha pulegium Species 0.000 claims 1
- 235000016257 Mentha pulegium Nutrition 0.000 claims 1
- 235000004357 Mentha x piperita Nutrition 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 229960000846 camphor Drugs 0.000 claims 1
- 238000005238 degreasing Methods 0.000 claims 1
- 235000001050 hortel pimenta Nutrition 0.000 claims 1
- 229940041616 menthol Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 3
- 208000004232 Enteritis Diseases 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- 210000000867 larynx Anatomy 0.000 abstract description 2
- 235000008935 nutritious Nutrition 0.000 abstract description 2
- 238000003756 stirring Methods 0.000 abstract description 2
- 208000007882 Gastritis Diseases 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 239000003440 toxic substance Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 241000220324 Pyrus Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000021017 pears Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 244000025361 Ficus carica Species 0.000 description 1
- 235000008730 Ficus carica Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010043515 Throat cancer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及一种无花果冻干粉含片,是由无花果冻干粉、复合桉叶油和硬脂酸镁均匀搅拌、造粒、烘干、压片而成。其中各原料组份含量为:无花果冻干粉50‑200份;复方桉叶油0.02‑0.08份,硬脂酸镁0.25‑1.0份。含片克服了目前无花果产品食用和携带便捷的问题。该发明集中了无花果的精华,营养丰富,食用量少,符合人们对科学饮食结构的要求,辅以复方桉叶油更增强了清咽、利喉和消肿、解毒的功效,同时还具有降低血压、血糖功能,对肠炎、胃炎也有很好的治疗作用,能提高人体免疫力,对癌细胞有抑制作用。
Description
技术领域:本发明涉及一种保健食品,尤其涉及一种主要以无花果为原料制备的无花果冻干粉含片及其制备工艺。
背景技术:《本草纲目》、《中药大词典》、《滇南本草》、《云南中草药》、《医林篆要》等药典称无花果为“神圣之果”、“圣果”、“奶浆果”、“太阳果”、“生命果”、“福寿之果”等。据记载:无花果性平、味甘。归肺、大肠经。有舒经活血、清肺润肠、理气健胃、消肿止痛之功效,用于治疗咳喘、喉痛、痰多、胸闷、肠炎、痢疾、便秘、痔疮、痈疮、疥癣、白癜风等,均有疗效。无花果也是《英国药典》中经官方审定的植物药之一。
现代营养医学研究证实,无花果含有大量的糖类、脂类、蛋白质、纤维素、多种维生素、多种无机盐及18种氨基酸,含有的苹果酸、柠檬酸、脂肪酶、蛋白酶、水解酶等,能健脾消食,降低和分解血脂的功能,可以减少脂肪在血管内的沉积。无花果含有的阿拉伯糖是玉米芯的649倍,能降低糖尿病人注射胰岛素的量,是预防、治疗糖尿病以及肥胖的一种特效药。无花果富含膳食纤维,其中的果胶和半纤维素吸水膨胀后能吸附多种化学物质,具有促进益生菌繁殖,消除人体“自由基”,使肠道内各种有害物质被吸附排出,能起到润肠通便、排毒养颜、抑制血糖升高、维持正常胆固醇含量的作用。
硒被誉为“生命的奇效”元素,有激活体内免疫系统细胞、抵抗疾病、延缓衰老的特殊功能。无花果是迄今为止发现的含硒量最高的水果,其含硒量是食用菌的100倍,是大蒜的400倍。无花果VC含量是柑橘的2.3倍、桃子的8倍、梨的2.7倍。含有的胡萝卜素,居于桃、葡萄、梅、梨、柑桔、甜柿之上。
美国科学研究表明,无花果丰富的钙,可以促进骨骼健康,可降低与年龄相关的黄斑变性的风险。丰富的钾可帮助控制血压,预防冠心病的作用。
据法国科学家研究,无花果含有一种苯甲酸类衍生物,能防治早期癌症的形成。日本医学专家己成功地从无花果中提取一种抗癌物质,用于肺癌、咽喉癌、食道癌、直肠癌、皮肤癌等的治疗。
据检测,每100克干无花果的营养化学组成是:总脂肪0.52克,饱和脂肪0.0克,胆固醇0.0克,总碳水化合物66.16克,总可食纤维12.21克,多糖49.0克,蛋白质4.3克,VA9.76毫克,VC0.68毫克,VB1 0.05毫克,VB2 0.05毫克,钙133.0毫克,视黄醇7微克,铁3.09毫克,钠34毫克,钾640毫克,锰0.48毫克,锌0.6毫克,铜0.37毫克,磷77毫克,核黄素0.1毫克,烟酸0.7毫克,胡萝卜素40微克。
目前无花果产品大部分被加工成干品、果脯、罐头、无花果汁、无花果酒。由于体积大,携带不方便,并且不易保存。
发明内容:为了克服无花果产品食用受到限制的问题,本发明的目的是提供一种老少皆宜、携带食用方便、易于保存的无花果冻干粉含片及其制备工艺。
本发明的技术方案是以下述方式实现的:
一种无花果冻干粉含片,它主要是以无花果冻干粉配以复方桉叶油而制成,其中各原料组份含量为:
无花果冻干粉 50-200份
复方桉叶油 0.02-0.12份
(1)、无花果冻干片超细粉磨得到60-1000目的无花果冻干粉;
(2)、冻干粉与复方桉叶油混匀后造粒、烘干;
(3)、压片、包装。
本发明的积极效果是:
1、使体积庞大的干果、鲜果变成包装精美携带方便的片剂形式,老少皆宜、易于吸收、易于保存;
2、无花果含片中集中了无花果的精华,营养丰富,食用量少,符合人们科学饮食结构的需求,辅以复方桉叶油更增强了清咽、利喉和消肿解毒的功效。
具体实施方式:
下面结合实施例对本发明作进一步说明:
实施例一、原料配方为:
无花果冻干粉50公斤;
复方桉叶油0.02公斤;
硬脂酸镁0.25公斤。
无花果冻干粉含片制备工艺:
(1)、将无花果冻干粉和硬脂酸镁搅拌均匀;
(2)、将搅拌均匀后的粉末与复方桉叶油混匀制成颗粒过14-20目筛;
(3)、颗粒在60-70℃下烘干后过14-20目筛;
(4)、干颗粒压片、包装。
实施例二、原料配方为:
无花果冻干粉50公斤;
复方桉叶油0.10公斤;
硬脂酸镁0.25公斤。
制备工艺同实施例一。
Claims (7)
1.一种复方无花果冻干粉含片,它主要是以无花果冻干粉配以复方桉叶油而制成,其中各原料组份含量为:
无花果冻干粉 50-200份
复方桉叶油 0.02-0.12份 。
2.一种如权利要求1所述的复方无花果冻干粉含片的制备工艺,它是将无花果冻干粉经下述步骤处理配置而成:
(1)、无花果冻干片超细粉磨得到无花果冻干粉;
(2)、冻干粉与复方桉叶油混匀后造粒、烘干;
(3)、压片、包装。
3.根据权利要求2所述的无花果含片的制备工艺,其特征在于:无花果冻干粉粉磨至60-1000目。
4.根据权利要求2所述的无花果冻干粉含片的制备工艺,其特征在于:无花果冻干粉与复方桉叶油混匀制成颗粒过14-20目筛、颗粒在60-70℃下烘干后过14-20目筛。
5.根据权利要求4所述的无花果冻干粉含片的制备工艺,其特征在于:干颗粒与配方量的复方桉叶油混合时,加入占总量0.4-0.6的硬脂酸镁。
6.根据权利要求5所述的无花果冻干粉含片的制备工艺,其复方桉叶油的配方为:薄荷脑1000克,精制樟脑68克,桉叶油900毫升,麝香草脑90克,丁香油250毫升,桂皮油670毫升。
7.根据权利要求6所述的无花果冻干粉含片的制备工艺,其复方桉叶油的制作方法为:将薄荷脑、樟脑、麝香草脑研成药末备用,将桉叶油、丁香油、桂皮油混合搅匀,再将药末倒入混合液中溶化,然后用消过毒的纱布或脱脂棉层过滤,便成为复方桉叶油。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610747603.7A CN107772330A (zh) | 2016-08-29 | 2016-08-29 | 一种复方无花果冻干粉含片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610747603.7A CN107772330A (zh) | 2016-08-29 | 2016-08-29 | 一种复方无花果冻干粉含片 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107772330A true CN107772330A (zh) | 2018-03-09 |
Family
ID=61441526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610747603.7A Withdrawn CN107772330A (zh) | 2016-08-29 | 2016-08-29 | 一种复方无花果冻干粉含片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107772330A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110024986A (zh) * | 2019-05-05 | 2019-07-19 | 四川农业大学 | 一种无花果功能性咀嚼片及其制备方法 |
CN110859870A (zh) * | 2019-11-20 | 2020-03-06 | 中国药科大学 | 一种无花果颗粒及其制备方法 |
-
2016
- 2016-08-29 CN CN201610747603.7A patent/CN107772330A/zh not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110024986A (zh) * | 2019-05-05 | 2019-07-19 | 四川农业大学 | 一种无花果功能性咀嚼片及其制备方法 |
CN110859870A (zh) * | 2019-11-20 | 2020-03-06 | 中国药科大学 | 一种无花果颗粒及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6416795B1 (en) | Herbal extract composition for stress prevention and treatment | |
CN108112973A (zh) | 一种辅助降三高组合物及其制备方法 | |
CN102224891A (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
CN106578801A (zh) | 一种具有降糖作用的综合酵素粉及其制备方法 | |
CN105494844A (zh) | 一种枸杞压片糖果生产方法 | |
CN107319086A (zh) | 一种枸杞金丝皇菊压片糖果及其制备方法 | |
CN107772330A (zh) | 一种复方无花果冻干粉含片 | |
CN105920198B (zh) | 一种具有补血功效的细胞破壁微粉及其制备方法 | |
CN105580953A (zh) | 一种桑枣压片糖果生产方法 | |
CN111467468A (zh) | 一种含人参、蛹虫草、生姜、枸杞子浓缩营养液及其制备方法 | |
CN106490558A (zh) | 一种保健蜂蜜及其制备方法 | |
CN109315558A (zh) | 一种姜枣茶泡腾片及其制备方法 | |
KR101446277B1 (ko) | 천연약재를 이용한 조성물 및 이의 제조방법 | |
CN108142751A (zh) | 一种保健饮料及其制备方法 | |
CN111418682A (zh) | 一种提升人体免疫功能的sod聚能香袋泡茶及其制备方法 | |
CN106165815A (zh) | 一种宣肺化痰平喘止咳饮料及制备加工方法 | |
KR102306903B1 (ko) | 미생물 대사산물을 포함하는 조성물 및 그 제조방법 | |
CN108079271A (zh) | 一种治疗高血脂的药物组合物、制剂及其制备方法 | |
KR102203094B1 (ko) | 천연물 유래 추출물을 포함하는 혈당 강하용 조성물 | |
KR102306902B1 (ko) | 저분자화 여주 추출물을 포함하는 조성물 및 그 제조방법 | |
CN102948663A (zh) | 一种林蛙油颗粒剂及其制备方法 | |
CN107495376A (zh) | 一种海藻胶为囊材的抗疲劳软胶囊制剂的制备方法 | |
CN107373657A (zh) | 一种蜂蛹粉的制备方法 | |
CN108112832A (zh) | 解酒护肝保健饮料 | |
CN105918911A (zh) | 一种糖尿病人适用的瘦身明目鸵鸟肉药膳及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180309 |